Cough Characteristics and FVC Maneuver in Cystic Fibrosis

References

1. 1.↵
   1. Farrell PM,
   2. Li Z,
   3. Kosorok MR,
   4. Laxova A,
   5. Green CG,
   6. Collins J,
   7. et al

   . Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol 2003;36(3):230–240.

   OpenUrlPubMedWeb of Science
2. 2.↵
   1. Mott LS,
   2. Park J,
   3. Murray CP,
   4. Gangell CL,
   5. de Klerk NH,
   6. Robinson PJ,
   7. et al

   . Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012;67(6):509–516.

   OpenUrlAbstract/FREE Full Text
3. 3.
   1. Ratjen F,
   2. Döring G

   . Clinical manifestations of pulmonary disease in cystic fibrosis. Lancet 2003;361(9358):681–689.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Rosenfeld M,
   2. Emerson J,
   3. Williams-Warren J,
   4. Pepe M,
   5. Smith A,
   6. Montgomery AB,
   7. Ramsey B

   . Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 2001;139(3):359–365.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Knudson RJ,
   2. Mead J,
   3. Knudson DE

   . Contribution of airway collapse to supra-maximal expiratory flows. J Appl Physiol 1974;36(6):653–667.

   OpenUrlFREE Full Text
6. 6.
   1. Pedersen OF,
   2. Lyager S,
   3. Ingram RH Jr.

   . Airway dynamics in transition between peak and maximal expiratory flow. J Appl Physiol 1985;59(6):1733–1746.

   OpenUrlAbstract/FREE Full Text
7. 7.
   1. Naire S

   . Dynamics of voluntary cough maneuvers: a theoretical model. J Biomech Eng 2009;131(1):011010.
8. 8.↵
   1. McCool FD

   . Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):48S–53S.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Dassios TG,
   2. Doudounakis S,
   3. Dimitriou G

   . Maximum rate of pressure development and maximal relaxation rate of respiratory muscles in patients with cystic fibrosis. Respir Care 2013;58(3):474–481.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Smith JA,
    2. Aliverti A,
    3. Quaranta M,
    4. McGuinness K,
    5. Kelsall A,
    6. Earis J,
    7. Calverley PM

    . Chest wall dynamics during voluntary and induced cough in healthy volunteers. J Physiol 2012;590(Pt 3):563–574.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Steinkamp G,
    2. Wiedemann B

    . Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002;57(7):596–601.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Bach JR,
    2. Saporito LR

    . Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. Chest 1996;110(6):1566–1571.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Vilozni D,
    2. Lavie M,
    3. Sarouk I,
    4. Efrati O

    . Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation? Am J Respir Crit Care Med 2012;186(1):82–87.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardization of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Beydon N,
    2. Davis SD,
    3. Lombardi E,
    4. Allen JL,
    5. Arets HG,
    6. Aurora P,
    7. et al

    . An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007;175(12):1304–1345.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Beardsmore CS,
    2. Wimpress SP,
    3. Thomson AH,
    4. Patel HR,
    5. Goodenough P,
    6. Simpson H

    . Maximum voluntary cough: an indication of airway function. Bull Eur Physiopathol Respir 1987;23(5):465–472.

    OpenUrlPubMedWeb of Science
17. 17.↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Cole TJ,
    4. Baur X,
    5. Hall GL,
    6. Culver BH,
    7. et al

    . ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324–1343.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Dassios T,
    2. Katelari A,
    3. Doudounakis S,
    4. Mantagos S,
    5. Dimitriou G

    . Respiratory muscle function in patients with cystic fibrosis. Pediatr Pulmonol 2013;48(9):865–873.

    OpenUrlPubMed
19. 19.↵
    1. Chaudri MB,
    2. Liu C,
    3. Hubbard R,
    4. Jefferson D,
    5. Kinnear WJ

    . Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002;19(3):434–438.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. King M

    . The role of mucus viscoelasticity in cough clearance. Biorheology 1987;24(6):589–597.

    OpenUrlPubMedWeb of Science
21. 21.↵
    1. Hamutcu R,
    2. Francis J,
    3. Karakoc F,
    4. Bush A

    . Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol 2002;34(5):331–335.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Smith JA,
    2. Owen EC,
    3. Jones AM,
    4. Dodd ME,
    5. Webb AK,
    6. Woodcock A

    . Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax 2006;61(5):425–429.

    OpenUrlAbstract/FREE Full Text